glp 1 for type 1 diabetes Could GLP-1 Receptor Agonists Help Prevent Infections in People with Diabetes? A Nationwide Study Says Yes—At Least the Lungs and Feet #ActAgainstAmputation #DiabeticFoot #GLP1RA GLP-1s for Weight Loss: What

The insurer will give its largest segment of customers, employers with 100 workers or more, the option of retaining coverage of the drugs for weight loss by paying an extra charge in their health plans

These studies comport with the human data to suggest GIP acts as an obesogenic factor in the context of overnutrition

Tirzepatide has demonstrated superior efficacy in both weight loss and blood glucose control compared to semaglutide (Aronne et al., 2025), highlighting the therapeutic potential of multi-agonist strategies

The findings inform opportunities for randomized trials to study SGLT2 inhibitors as potential treatments to mitigate dementia risk in an older population

Does the VA require diabetes for Ozempic coverage